Lupin rolls out Lurasidone Hydrochloride in US for bipolar depression
Lupin Limited said that it has rolled out Lurasidone Hydrochloride Tablets in the strengths of 20mg, 40mg, 60mg, 80mg, and 120mg in the US. Lurasidone ... Read More
Lupin gets approval for overactive bladder syndrome drug generic
Lupin Limited has secured approval for its abbreviated new drug application (ANDA) for Fesoterodine Fumarate Extended-Release Tablets, 4 mg and 8 mg from the United ... Read More
Lupin ropes in Spiro Gavaris as US generics business president
Indian pharmaceutical company Lupin Limited has appointed Spiro Gavaris as president of its US generics business. Spiro Gavaris, who will be a part of the ... Read More
Lupin launches generic version of arthritis drug PENNSAID in US
Lupin Limited has announced the US launch of authorized generic version of Horizon Pharma Therapeutics’ PENNSAID (Diclofenac Sodium Topical Solution), 2% w/w. Diclofenac Sodium Topical ... Read More
Lupin announces US launch of Formoterol Fumarate Inhalation Solution
Indian pharma company Lupin Limited has launched Formoterol Fumarate Inhalation Solution, 20 mcg/2 mL per Unit-Dose Vial in the US market. The product is a ... Read More
Lupin subsidiary MedQuímica buys rights to nine drugs from Bausch Health
Lupin Limited said that MedQuímica Indústria Farmacêutica, its 100% subsidiary in Brazil, has agreed to acquire all rights to nine drugs from Bausch Health Companies’ ... Read More
Lupin Limited gets FDA tentative approval for rosacea drug generic
India-based Lupin Limited said that it has obtained tentative approval for its abbreviated new drug application (ANDA) of Doxycycline Capsules, 40 mg from the US ... Read More
Lupin gets FDA tentative approval for generic of contraceptive pill
Lupin Limited has secured tentative approval for its Abbreviated New Drug Application (ANDA) for Drospirenone Tablets, 4 mg from the US Food and Drug Administration ... Read More
Lupin launches schizophrenia drug Invega generic in US
Indian pharma company Lupin Limited has launched Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and 9 mg in the US. The product is ... Read More
Lupin to acquire rights to Brovana and Xopenex HFA for $75m
Lupin Limited has agreed to acquire all rights to a couple of inhalation medicines, namely Brovana (arformoterol tartrate) Inhalation Solution and Xopenex HFA (levalbuterol tartrate) ... Read More